Our data depict that in dependence on the tumor entity and time after treatment, the surface expression of PD-L1 differs (Figures 2–4) and is partially linked with IFN-gamma expression and IL-6 release (Figures 5 and 6). The gene discussed is IFNG; the disease is neoplasm.